SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-81174"
 

Search: onr:"swepub:oai:DiVA.org:oru-81174" > Predicting outcome ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Predicting outcome in hyper-acute stroke : validation of a prognostic model in the Third International Stroke Trial (IST3)

Lewis, Steff C. (author)
Division of Clinical Neurosciences, University of Edinburgh, United Kingdom; Neurosciences Trials Unit, Division of Clinical Neurosciences, Western General Hospital, Edinburgh, United Kingdom
Sandercock, Peter A. G. (author)
Division of Clinical Neurosciences, University of Edinburgh, United Kingdom; Western General Hospital, Edinburgh, United Kingdom
Dennis, Martin S. (author)
Division of Clinical Neurosciences, University of Edinburgh, United Kingdom; Western General Hospital, Edinburgh, United Kingdom
show more...
SCOPE, (Stroke Complications and Outcomes Prediction Engine) Collaborations (author)
IST, - (author)
von Euler, Mia, 1967- (author)
Terent, Andreas (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
show less...
 (creator_code:org_t)
London, UK : BMJ Publishing Group Ltd, 2008
2008
English.
In: Journal of Neurology, Neurosurgery and Psychiatry. - London, UK : BMJ Publishing Group Ltd. - 0022-3050 .- 1468-330X. ; 79:4, s. 397-400
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND AND PURPOSE: Models are used to adjust for case mix and to stratify treatment allocation in clinical trials and can, if accurate enough, be used to aid decision-making in individual patients. We aimed to validate, in patients assessed within 6 hours of onset, a previously described six simple variable (SSV) model that was developed in stroke patients who were assessed sub-acutely. The explanatory variables in the model are age, living alone, independent pre-stroke, Glasgow Coma Scale verbal score, ability to lift arms and ability to walk.METHODS: The six variables were collected at randomisation in the Third International Stroke Trial (IST3) trial of recombinant tissue plasminogen activator in ischaemic stroke. We assessed survival to 30 days and functional status at 6 months using the Oxford Handicap Scale. We constructed receiver operator characteristic (ROC) curves to establish the model's discriminatory performance and tested its calibration by charting predicted versus actual outcomes.RESULTS: 537 patients (mean age, 74 years) were included, of whom 422 (79%) survived 30 days and 179 (33%) were alive and independent at 6 months. The SSV model had an area under the ROC curve of 0.73 for 30-day survival and 0.82 for independent survival at 6 months. Calibration was satisfactory.CONCLUSIONS: This study confirms the external validity of the SSV model in an ischaemic stroke population assessed within 6 hours of symptom onset. The SSV model comprising easily collected variables can therefore be used to stratify patients in hyper-acute stroke trials, but probably is not accurate enough for decision-making in individual patients.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

MEDICINE

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view